3Shimamoto K, Saito T, Okadome M, et al. Prognostic significance of the treatment-free interval in patients with recurrent endometrial cancer [ J ]. Eur J Obstet Gynecol Reprod Biol,2014,175:92 - 96.
4Bowes H,Jones G,Thompson J, et al. Understanding the impact of the treatment pathway upon the health-related quality of life of women with newly diagnosed endometrial cancer - a qualitative study[J]. Eur J Oncol Nurs,2014,18(2) :211 -217.
5Dias DS, Bueloni-Dias FN, Dias R, et al. Usefu~tness of clinical, ul- trasonographic, hysteroscopic, and immunohistochemical parameters in differentiating endometrial polyps from endometrial cancer [J]. J Minim Invasive Gynecol,2014,21 (2) :296 -302.
6Ko EM, Walter P, Jackson A, et al. Metformin is associated with im- proved survival in endometrial cancer[ J]. Gynecol Oncol,2014,132 (2) :438 -442.
7Koskas M, Genin AS, Graesslin O, et al. Evaluation of a method of predicting lymph node metastasis in endometrial cancer based on five pre-operative characteristics [ J ]. Eur J Obstet Gynecol Reprod Biol, 2014,172 : 115 - 119.
8Delotte J, Desantis M, Frigenza M, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of endo- metrial cancer with peritoneal carcinomatosis [ J ]. Eur J Obstet Gy- necol Reprod Bio1,2014,172 : 111 - 114.
